Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
89.60
+1.03 (1.16%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Merit Medical Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
145.56128.49120.3694.4174.5248.45
Depreciation & Amortization
135.89134.65114.73101.2992.295.78
Other Amortization
5.665.666.771.720.60.6
Loss (Gain) From Sale of Assets
-10.12.051.495.411.81.3
Asset Writedown & Restructuring Costs
0.50.310.461.798.454.41
Loss (Gain) From Sale of Investments
---0.270.5-
Stock-Based Compensation
45.3943.4628.4721.3318.0416.09
Other Operating Activities
4.96.1-14.53-11.04-10.42-1.58
Change in Accounts Receivable
-21.36-7.34-13.69-11.92-15.12-8.62
Change in Inventory
-53.46-21.6-2.29-32.11-47.93-25.18
Change in Accounts Payable
7.511.01-2.31-7.312.666.05
Change in Income Taxes
8.513.94-2.41-1.846.051.06
Change in Other Net Operating Assets
13.60.64-16.25-16.87-27.068.85
Operating Cash Flow
283.45297.37220.8145.15114.29147.23
Operating Cash Flow Growth
18.13%34.68%52.12%27.00%-22.37%-10.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-80.24-81.72-35.14-34.29-45.03-27.94
Sale of Property, Plant & Equipment
25.560.30.010.630.071.04
Cash Acquisitions
-115.21-144.77-320.18-134.52-6.88-7.17
Divestitures
-----0.97-
Sale (Purchase) of Intangibles
-3.44-3.12-2.9-2.41-3.18-2.83
Other Investing Activities
-3.47-18.08-10.43-4.76-1.41-0.25
Investing Cash Flow
-176.8-247.39-368.65-175.35-57.4-37.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---1,199215.2198.42
Long-Term Debt Repaid
---99.06-579.62-260.14-206.92
Net Debt Issued (Repaid)
---99.06619.58-44.94-108.5
Issuance of Common Stock
12.8228.2140.9115.5820.0721.31
Repurchase of Common Stock
-10.36-9.53-1.59-5.12-2.47-0.58
Other Financing Activities
-3.11-2.69-0.26-70.77-32.92-10.67
Financing Cash Flow
-0.6416-60.01559.27-60.26-98.44

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.993.8-2.52-0.48-3.83-0.8
Net Cash Flow
106.9969.78-210.38528.59-7.1910.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
203.21215.66185.66110.8669.26119.29
Free Cash Flow Growth
5.66%16.16%67.47%60.06%-41.94%0.01%
Free Cash Flow Margin
12.87%14.23%13.69%8.82%6.02%11.10%
Free Cash Flow Per Share
3.393.573.131.901.202.08
Levered Free Cash Flow
173.9179.71184.91106.251.35142.07
Unlevered Free Cash Flow
188.1190.59197.65114.1754.7144.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
23.2820.9923.2414.056.265.26
Cash Income Tax Paid
33.6131.3945.0531.5317.098.83
Change in Working Capital
-45.21-23.34-36.95-70.02-71.4-17.84
SEC Filings: 10-K · 10-Q